DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Ryan CW, Goldman BH, Lara Jr PN, Mack PC, Beer TM, Tangen CM, Lemmon D, Pan CX, Drabkin HA, Crawford ED.
Sorafenib with interferon alfa-2b as first-line treatment of
advanced renal carcinoma: a phase II study of the Southwest Oncology
Group.
J Clin Oncol 2007; 25: 3296-3301
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.